On the first of November a new Shingles from British Biotech and pharmaceutical Company GlaxoSmithKline. The new vaccine named Shingrix® will replace the previously available Zostavax® and the Shingrix® has been made free to five million Australians who have been deemed the most venerable to Shingles.
The vaccine which needs two doses will cost the government up to $560 for the full vaccination, with a total investment of $826.8 million dollars to the National Immunisation Program (NIP).
Produced By: Dominic Giles
Featured In Story: Professor Frank Beard from the School of Public Health, National Centre for Immunisation Research & Surveillance at the University of Sydney.
First aired on The Wire, Tuesday 28 November 2023